WO2025233092 - COMPOSITION FOR MAINTAINING AND/OR IMPROVING EYE HEALTH OR VISUAL FUNCTION
National phase entry is expected:
Publication Number
WO/2025/233092
Publication Date
13.11.2025
International Application No.
PCT/EP2025/060339
International Filing Date
15.04.2025
Title **
[English]
COMPOSITION FOR MAINTAINING AND/OR IMPROVING EYE HEALTH OR VISUAL FUNCTION
[French]
COMPOSITION POUR MAINTENIR ET/OU AMÉLIORER LA SANTÉ OCULAIRE OU LA FONCTION VISUELLE
Applicants **
SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Inventors
TROVO, Laura
SULTAN, Sebastien, Maurice
Priority Data
63/644,067
08.05.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1997 | |
| EPO | Filing, Examination, Granting | 8107 | |
| Japan | Filing, Examination, Granting | 2122 | |
| South Korea | Filing, Examination, Granting | 2004 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
18,970
Contact Us
Abstract[English]
The present invention relates to compositions for use in maintaining and/or improving eye health and/or visual function in an individual consisting essentially of taurine and vitamin B9.[French]
La présente invention concerne des compositions destinées à être utilisées pour maintenir et/ou améliorer la santé oculaire et/ou la fonction visuelle chez un individu, constituées essentiellement de taurine et de vitamine B9.